P48Q (p.Pro48Gln) variant of SOST (Sclerostin)

P48Q (p.Pro48Gln) in SOST (Sclerostin) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.17 / 1. The record also includes population frequency data and structural context.

P48Q (p.Pro48Gln) variant details